SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September 20, 2017, between Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT northwest biotherapeutics, inc.Common Stock Purchase Warrant • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business at 5:00 p.m. (New York City time) on _____1 (the “Termination Date) but not thereafter, to subscribe for and purchase from Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIALLetter Agreement • September 22nd, 2017 • Northwest Biotherapeutics Inc • Pharmaceutical preparations • New York
